
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Worldwide Strategies Incorporated (CE) | USOTC:WWSG | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 20 | 00:00:00 |
ý | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Nevada
|
41-0946897
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
3801 East Florida Avenue, Suite 400, Denver, Colorado
|
80210
|
(Address of principal executive offices)
|
(Zip Code)
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer ☐
|
Smaller reporting company ý
|
Page
|
|||
PART I. FINANCIAL INFORMATION
|
|||
Item 1.
|
Financial Statements
|
||
Consolidated Condensed Balance Sheets (unaudited)
|
2
|
||
Consolidated Condensed Statements of Operations (unaudited)
|
3
|
||
Consolidated Condensed Statement of Changes in Shareholders' Deficit (unaudited)
|
4
|
||
Consolidated Condensed Statements of Cash Flows (unaudited)
|
5
|
||
Notes to Consolidated Condensed Financial Statements (unaudited)
|
6
|
||
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
12
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
14
|
|
Item 4.
|
Controls and Procedures
|
15
|
|
PART II. OTHER INFORMATION
|
|||
Item 1.
|
Legal Proceedings
|
16
|
|
Item 1A.
|
Risk Factors
|
16
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
16
|
|
Item 3.
|
Defaults Upon Senior Securities
|
16
|
|
Item 4.
|
Mine Safety Disclosures
|
16
|
|
Item 5.
|
Other Information
|
16
|
|
Item 6.
|
Exhibits
|
17
|
|
SIGNATURES
|
18
|
April 30,
|
July 31,
|
|||||||
2014
|
2013
|
|||||||
Assets
|
||||||||
Current Assets:
|
||||||||
Cash
|
$ |
|
8,649
|
$ |
|
3,537
|
||
Total current assets
|
8,649
|
3,537
|
||||||
Deposits
|
150
|
150
|
||||||
Total assets
|
$ |
|
8,799
|
$ |
|
3,687
|
||
Liabilities and Shareholders' Deficit
|
||||||||
Current Liabilities:
|
||||||||
Accounts and notes payable:
|
||||||||
Accounts payable
|
$ |
|
83,022
|
$ |
|
84,846
|
||
Accounts payable, related party
|
3,900
|
3,900
|
||||||
Accrued liabilities
|
37,584
|
26,503
|
||||||
Accrued liabilities, related party
|
14,553
|
4,723
|
||||||
Notes payable, related party, net of unamortized discount
|
||||||||
of $2,740 and $45,822, respectively
|
70,434
|
11,445
|
||||||
Note payable, related party, in default
|
65,000
|
65,000
|
||||||
Note payable, net of unamortized discount of $5,126 and
|
||||||||
$8,644, respectively
|
164,911
|
135,300
|
||||||
Total current liabilities
|
439,404
|
331,717
|
||||||
Shareholders' deficit:
|
||||||||
Preferred stock, $.001 par value; 25,000,000 shares authorized,
|
||||||||
1,491,743 shares issued and outstanding
|
1,492
|
1,492
|
||||||
Common stock, $.001 par value, 33,333,333 shares authorized
|
||||||||
19,830,672 and 18,859,005 shares issued and outstanding respectively
|
19,831
|
18,860
|
||||||
Stock Payable
|
—
|
36,000
|
||||||
Additional paid-in capital
|
7,688,896
|
7,575,567
|
||||||
Accumulated deficit
|
(8,140,824
|
)
|
(7,959,949
|
)
|
||||
Total shareholders' deficit
|
(430,605
|
)
|
(328,030
|
)
|
||||
Total liabilities and shareholders' deficit
|
$ |
|
8,799
|
$ |
|
3,687
|
||
Nine Months Ended
|
Three Months Ended
|
|||||||||||||||
April 30,
|
April 30,
|
|||||||||||||||
2014
|
2013
|
2014
|
2013
|
|||||||||||||
Sales
|
$ |
|
—
|
$ |
|
—
|
$ |
|
—
|
$$ |
—
|
|||||
Cost of sales
|
—
|
—
|
—
|
—
|
||||||||||||
—
|
—
|
—
|
—
|
|||||||||||||
Operating expenses:
|
||||||||||||||||
Professional and consulting fees
|
30,391
|
47,341
|
3,050
|
9,711
|
||||||||||||
Travel
|
601
|
7,231
|
—
|
—
|
||||||||||||
Other general and administrative expenses
|
4,073
|
3,330
|
966
|
495
|
||||||||||||
Total operating expenses
|
35,065
|
57,902
|
4,016
|
10,206
|
||||||||||||
Loss from operations
|
(35,065
|
)
|
(57,902
|
)
|
(4,016
|
)
|
(10,206
|
)
|
||||||||
Other expense:
|
||||||||||||||||
Interest expense
|
(145,810
|
)
|
(62,376
|
)
|
(25,203
|
)
|
(44,410
|
)
|
||||||||
Loss before income taxes
|
(180,875
|
)
|
(120,278
|
)
|
(29,219
|
)
|
(54,615
|
)
|
||||||||
Income tax provision
|
—
|
—
|
—
|
—
|
||||||||||||
Net loss
|
$ |
|
(180,875
|
)
|
$ |
|
(120,278
|
)
|
$ |
|
(29,219
|
)
|
(54,615
|
)
|
||
Basic and diluted loss per share
|
$ |
|
(0.01
|
)
|
$ |
|
(0.01
|
)
|
$ |
|
(0.00
|
)
|
$ |
|
(0.00
|
)
|
Basic and diluted weighted average
|
||||||||||||||||
common shares outstanding
|
19,557,290
|
17,938,398
|
19,702,582
|
18,447,130
|
||||||||||||
Common
|
||||||||||||||||||||||||||||||||||||
Stock
|
Additional
|
|||||||||||||||||||||||||||||||||||
Preferred Stock
|
Common Stock
|
Subscriptions
|
Stock
|
Paid-In
|
Accumulated
|
|||||||||||||||||||||||||||||||
Shares
|
Par Value
|
Shares
|
Par Value
|
Receivable
|
Payable
|
Capital
|
Deficit
|
Total
|
||||||||||||||||||||||||||||
Balance at July 31, 2012 (restated)
|
1,491,743
|
$ |
|
1,492
|
16,870,234
|
$ |
|
16,871
|
$
|
—
|
$ |
|
37,500
|
$ |
|
6,896,455
|
$ |
|
(7,727,268
|
)
|
$ |
|
(774,950
|
)
|
||||||||||||
Common stock issued in exchange for
|
||||||||||||||||||||||||||||||||||||
interest, related party
|
—
|
—
|
1,453,771
|
1,454
|
—
|
(1,500
|
)
|
42,528
|
—
|
42,482
|
||||||||||||||||||||||||||
Common stock issued in exchange for
|
||||||||||||||||||||||||||||||||||||
CFO compensation
|
—
|
—
|
150,000
|
150
|
—
|
—
|
1,350
|
—
|
1,500
|
|||||||||||||||||||||||||||
Common stock issued for consulting
|
||||||||||||||||||||||||||||||||||||
services
|
—
|
—
|
385,000
|
385
|
—
|
—
|
4,165
|
—
|
4,550
|
|||||||||||||||||||||||||||
Options issued in exchange for
|
||||||||||||||||||||||||||||||||||||
board member services (Aug 2012)
|
—
|
—
|
—
|
—
|
—
|
—
|
5,000
|
—
|
5,000
|
|||||||||||||||||||||||||||
Options issued in exchange for
|
||||||||||||||||||||||||||||||||||||
CFO compensation (Aug 2012)
|
—
|
—
|
—
|
—
|
—
|
—
|
1,500
|
—
|
1,500
|
|||||||||||||||||||||||||||
Options issued in exchange for
|
||||||||||||||||||||||||||||||||||||
board member services (Jul 2013)
|
—
|
—
|
—
|
—
|
—
|
—
|
60,000
|
—
|
60,000
|
|||||||||||||||||||||||||||
Options issued in exchange for
|
||||||||||||||||||||||||||||||||||||
CFO compensation (Jul 2013)
|
—
|
—
|
—
|
—
|
—
|
—
|
18,000
|
—
|
18,000
|
|||||||||||||||||||||||||||
Foregiveness Of Past Salary And
|
||||||||||||||||||||||||||||||||||||
Expenses To CEO and Former CFO
|
—
|
—
|
—
|
—
|
—
|
—
|
474,019
|
—
|
474,019
|
|||||||||||||||||||||||||||
Beneficial conversion feature
|
—
|
—
|
—
|
—
|
—
|
—
|
72,550
|
—
|
72,550
|
|||||||||||||||||||||||||||
Net loss for the year ended July 31, 2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(232,681
|
)
|
(232,681
|
)
|
|||||||||||||||||||||||||
Balance at July 31, 2013
|
1,491,743
|
$ |
|
1,492
|
18,859,005
|
$ |
|
18,860
|
$ |
|
—
|
$ |
|
36,000
|
$ |
|
7,575,567
|
$ |
|
(7,959,949
|
)
|
$ |
|
(328,030
|
)
|
|||||||||||
Common stock issued in exchange for
|
||||||||||||||||||||||||||||||||||||
interest and note extension, related party
|
—
|
—
|
671,667
|
671
|
—
|
—
|
39,629
|
—
|
40,300
|
|||||||||||||||||||||||||||
Common stock authorized for Feb 2012
|
||||||||||||||||||||||||||||||||||||
but not issued until March 2014
|
—
|
—
|
300,000
|
300
|
—
|
(36,000
|
)
|
35,700
|
—
|
|||||||||||||||||||||||||||
Beneficial conversion feature
|
—
|
—
|
—
|
—
|
—
|
—
|
38,000
|
—
|
38,000
|
|||||||||||||||||||||||||||
Net loss
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(180,875
|
)
|
(180,875
|
)
|
|||||||||||||||||||||||||
Balance at April 30, 2014
|
1,491,743
|
$ |
|
1,492
|
19,830,672
|
$ |
|
19,831
|
$ |
|
—
|
$ |
|
—
|
$ |
|
7,688,896
|
$ |
|
(8,140,824
|
)
|
$ |
|
(430,605
|
)
|
|||||||||||
For the Nine Months Ended
|
||||||||
April 30,
|
||||||||
2014
|
2013
|
|||||||
Cash flows from operating activities:
|
||||||||
Net loss
|
$ |
|
(180,875
|
)
|
$ |
|
(120,278
|
)
|
Adjustments to reconcile net loss to net cash
|
||||||||
used in operating activities:
|
||||||||
Amortization of beneficial conversion feature
|
84,599
|
9,931
|
||||||
Stock based compensation
|
—
|
1,500
|
||||||
Stock issued for promissory note extension
|
40,300
|
6,500
|
||||||
Consulting expense paid in common stock
|
—
|
4,550
|
||||||
Interest expense paid in common stock
|
—
|
24,981
|
||||||
Changes in current assets and liabilities:
|
||||||||
Accounts payable and accrued liablities
|
9,258
|
21,256
|
||||||
Accounts payable and accrued
|
||||||||
liabilities, related party
|
9,830
|
9,690
|
||||||
Net cash used in operating activities
|
(36,889
|
)
|
(41,870
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Proceeds from notes payable, related party
|
16,000
|
2,500
|
||||||
Proceeds from notes payable
|
26,000
|
35,000
|
||||||
Net cash provided by financing activities
|
42,000
|
37,500
|
||||||
Net change in cash
|
5,111
|
(4,370
|
)
|
|||||
Cash, beginning of period
|
3,537
|
4,709
|
||||||
Cash, end of period
|
$ |
|
8,649
|
$ |
|
339
|
||
Supplemental disclosure of cash flow information:
|
||||||||
Cash paid during the period for:
|
||||||||
Income taxes
|
$ |
|
—
|
$ |
|
—
|
||
Interest
|
$ |
|
—
|
$ |
|
—
|
||
Non-cash investing/financing activities
|
||||||||
Stock issued for conversion of accrued interest
|
—
|
5,187
|
||||||
Beneficial Conversion Feature - Debt
|
38,000
|
15,000
|
||||||
Common shares issued out of stock payable
|
36,000
|
1,500
|
||||||
·
|
Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income
|
|
|
|
- but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and
|
·
|
Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.
|
Regulation S-K Number
|
Exhibit
|
2.1
|
Share Exchange Agreement by and between Worldwide Strategies Incorporated, Centric Rx, Inc., Jim Crelia, Jeff Crelia, J. Jireh, Inc. and Canada Pharmacy Express, Ltd. dated as of June 28, 2007 (1)
|
3.1
|
Amended and Restated Articles of Incorporation (2)
|
3.2
|
Amended Bylaws (2)
|
3.3
|
Articles of Exchange Pursuant to NRS 92A.200 effective July 31, 2007 (3)
|
3.4
|
Certificate of Change Pursuant to NRS 78.209 effective July 31, 2007 (3)
|
3.5
|
Certificate of Designation Pursuant to NRS 78.1955 effective December 8, 2008 (4)
|
3.6
|
Amendment to Certificate of Designation Pursuant to NRS 78.1955 effective December 15, 2008 (5)
|
10.1
|
2005 Stock Plan (2)
|
10.2
|
Acknowledgement of Debt Satisfaction and Full Release with James P.R. Samuels dated as of July 31, 2013 (6)
|
10.3
|
Acknowledgement of Debt Satisfaction and Full Release with W. Earl Somerville dated as of July 31, 2013 (6)
|
31.1
|
Rule 13a-14(a) Certification of James P.R. Samuels
|
31.2
|
Rule 13a-14(a) Certification of Thomas E. McCabe
|
32.1
|
Certification of James P.R. Samuels Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002
|
32.2
|
Certification of Thomas E. McCabe Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002
|
101
|
Interactive Data Files
|
(1)
|
Filed as an exhibit to the Current Report on Form 8-K dated June 28, 2007, filed July 2, 2007.
|
(2)
|
Filed as an exhibit to the initial filing of the registration statement on Form SB-2, File No. 333-129398, on November 2, 2005.
|
(3)
|
Filed as an exhibit to the Current Report on Form 8-K dated July 31, 2007, filed August 6, 2007.
|
(4)
|
Filed as an exhibit to the Current Report on Form 8-K dated December 8, 2008, filed December 10, 2008.
|
(5)
|
Filed as an exhibit to the Current Report on Form 8-K dated December 15, 2008, filed December 17, 2008.
|
(6)
|
Filed as an exhibit to the Annual Report on Form 10-K for the fiscal year ended July 31, 2014, filed February 17, 2015.
|
WORLDWIDE STRATEGIES INCORPORATED
|
||
Date: 01 April 2015
|
By:
|
|
James P.R. Samuels
|
||
Chief Executive Officer
|
||
(Principal Executive Officer)
|
||
Date: 01 April 2015
|
By:
|
|
Thomas E. McCabe
|
||
Chief Financial Officer
|
||
(Principal Financial Officer and Principal Accounting Officer)
|
1. | I have reviewed this Quarterly Report on Form 10-Q of Worldwide Strategies Incorporated; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: 01 April 2015
|
By:
|
|
James P.R. Samuels, CEO
|
||
Principal Executive Officer
|
1. | I have reviewed this Quarterly Report on Form 10-Q of Worldwide Strategies Incorporated; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: 01 April 2015
|
By:
|
|
Thomas E. McCabe, CFO
|
||
Principal Financial Officer
|
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: 01 April 2015
|
By:
|
|
James P.R. Samuels, CEO
|
||
Principal Executive Officer
|
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: 01 April 2015
|
By:
|
|
Thomas E. McCabe, CFO
|
||
Principal Financial Officer
|
1 Year Worldwide Strategies (CE) Chart |
1 Month Worldwide Strategies (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions